|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Single-port technique evolution and current practice in urologic procedures显示文摘Different groups described the single-port surgery since its first report in laparoscopic procedures.However,the acceptance of this technique among urologists,even after the robotic approach,was reduced in the past years.Therefore,to overcome the challenges related to the single-port surgery,a new robotic platform named da Vinci SP was created with exclusive single port technology.We performed a non-systematic literature review regarding the single port technique in urologic surgeries since the first laparoscopic report until the da Vinci SP robotic platform.Three different periods were described(laparoscopy,robotic,and da Vinci SP),and we focused in our experience with this new single port robot.We selected different articles and summarized the information regarding the use of single-site surgery in laparoscopic procedures and the challenges of this approach.We also reported the experience of different groups using the single port robotic technique and some recent reports of the da Vinci SP approach.In our experience with this new console,we described some critical points related to our radical prostatectomy technique and the lessons learned during the introduction of this novel platform.Previous single-site procedures described some common challenges that limited the technique expansion.However,our experience with the da Vinci SP described feasible and safe procedures with acceptable intraoperative outcomes.The introduction of this platform is recent in the market,and the literature still lacks a high level of evidence describing the long-term outcomes of this new technology. | Marcio Covas Moschovas Kulthe Ramesh Seetharam Bhat Fikret Fatih Onol Travis Rogers Gabriel Ogaya-Pinies Shannon Roof Vipul R.Patel | 2021 | Asian Journal of Urology2021，8，1： | 3 |
| 2 | Magnetic resonance imaging-guided prostate biopsydA review of literature显示文摘Objective:Multiparametric magnetic resonance imaging(MP-MRI)helps to identify lesion of prostate with reasonable accuracy.We aim to describe the various uses of MP-MRI for prostate biopsy comparing different techniques of MP-MRI guided biopsy.Materials and methods:A literature search was performed for“multiparametric MRI”,“MRI fusion biopsy”,“MRI guided biopsy”,“prostate biopsy”,“MRI cognitive biopsy”,“MRI fusion biopsy systems”,“prostate biopsy”and“cost analysis”.The search operation was performed using the operator“OR”and“AND”with the above key words.All relevant systematic reviews,original articles,case series,and case reports were selected for this review.Results:The sensitivity of MRI targeted biopsy(MRI-TB)is between 91%e93%,and the specificity is between 36%e41%in various studies.It also has a high negative predictive value(NPV)of 89%e92%and a positive predictive value(PPV)of 51%e52%.The yield of MRI fusion biopsy(MRI-FB)is similar,if not superior to MR cognitive biopsy.In-bore MRI-TB had better detection rates compared to MR cognitive biopsy,but were similar to MR fusion biopsy.Conclusions:The use of MRI guidance in prostate biopsy is inevitable,subject to availability,cost,and experience.Any one of the three modalities(i.e.MRI cognitive,MRI fusion and MRI in-bore approach)can be used.MRI-FB has a fine balance with regards to accuracy,practicality and affordability. | Kulthe Ramesh Seetharam Bhat Srinivas Samavedi Marcio Covas Moschovas Fikret Fatih Onol Shannon Roof Travis Rogers Vipul R.Patel Ananthakrishnan Sivaraman | 2021 | Asian Journal of Urology2021，8，1： | 3 |
| 3 | Cystic Pancreatic Neoplasms: Observe or Operate显示文摘 | Kristine S. Spinelli Travis E. Fromwiller Roger A. Daniel James M. Kiely Attila Nakeeb Richard A. Komorowski Stuart D. Wilson Henry A. Pitt | 2004 | Annals of Surgery2004，，5： | 1 |
| 4 | Risk for Colorectal Neoplasia in Patients With Colonic Crohn’s Disease and Concomitant Primary Sclerosing Cholangitis显示文摘 | Barbara Braden Johnny Halliday Sanjeewa Aryasingha Yalda Sharifi Davide Checchin Bryan F. Warren Taya Kitiyakara Simon P.L. Travis Roger W. Chapman | 2012 | Clinical Gastroenterology and Hepatology2012，，3： | 1 |
| 5 | Robotic renal and adrenal oncologic surgery:A contemporary review显示文摘Robot-assisted surgery has evolved over time.Radical nephrectomy with inferior vena cava thrombectomy is feasible and safe for level I,II and III thrombus in high volume centers.Though it is feasible for level IV thrombus,this procedure needs a multi-departmental cooperation.However,the safety of robot-assisted procedures in this subset is still unknown.Robot-assisted partial nephrectomy has been universally approved and found oncologically safe.Robotic adrenalectomy has been increasingly utilized for select cases,especially in bilateral tumors and for retroperitoneal adrenalectomy. | Kulthe Ramesh Seetharam Bhat Marcio Covas Moschovas Fikret Fatih Onol Travis Rogers Shannon Roof Vipul R.Patel Oscar Schatloff | 2021 | Asian Journal of Urology2021，8，1： | 1 |
| 6 | Risk for Colorectal Neoplasia in Patients With Colonic Crohn’s Disease and Concomitant Primary Sclerosing Cholangitis显示文摘 | Barbara Braden Johnny Halliday Sanjeewa Aryasingha Yalda Sharifi Davide Checchin Bryan F. Warren Taya Kitiyakara Simon P.L. Travis Roger W. Chapman | 2012 | Clinical Gastroenterology and Hepatology2012，，3： | 1 |
| 7 | Oncologic outcomes with and without amniotic membranes in robotic-assisted radical prostatectomy:A propensity score matched analysis显示文摘Objective:Placement of human placenta derived grafts during robotic-assisted radical prostatectomy(RARP)hastens the return of continence and potency.The long-term impact on the oncologic outcomes remains to be investigated.Our objective was to determine the oncologic outcomes of patients with dehydrated human amnion chorion membrane(dHACM)at RARP compared to a matched cohort.Methods:In a referral centre,from August 2013 to October 2019,599 patients used dHACM in bilateral nerve-sparing RARP.We excluded patients with less than 12 months follow-up,simple prostatectomy,and unilateral nerve-sparing.Patients with dHACM(amnio group)were 529,and were propensity score matched 1:1 to 2465 patients without dHACM(non-amnio group)and a minimum follow-up of 36 months.At the time of RARP,dHACM was placed around the neurovascular bundle in the amnio group.Continuous and categorical variables in matched groups was tested by two-sample Kolmogorov-Smirnov test and Fisher's exact test respectively.Outcomes measured were biochemical recurrence(BCR),adjuvant and salvage therapy rates.Results:Propensity score matching resulted in two groups of 444 patients.Cumulative incidence functions for BCR did not show a difference between the groups(p=0.3).Patients in the non-amnio group required salvage therapy more frequently than the amnio group,particularly after partial nerve-sparing RARP(6.3%vs.2.3%,p=0.001).Limitations are the absence of prospective randomization.Conclusion:The data suggest that using dHACM does not have a negative impact on BCR in patients.Outcomes of cancer specific and overall survival will require follow-up study to increase our understanding of these grafts’impact on prostate cancer biology. | Jonathan Noël Daniel Stirt Marcio Covas Moschovas Sunil Reddy Abdel Rahman Jaber Marco Sandri Seetharam Bhat Travis Rogers Subuhee Ahmed Anya Mascarenhas Ela Patel Vipul Patel | 2024 | Asian Journal of Urology2024，11，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员